Genetic Test Evaluation

understanding how genetic tests impact patient management

Oncotype DX Breast DCIS Score (Genomic Health Inc.)

November 8, 2018

According to the testing laboratory, the Oncotype DX Breast DCIS Score test is used to aid in predicting the risk of 10-year local or invasive cancer recurrence and establish a baseline for consideration of absolute benefit from radiation therapy in women diagnosed with ductal carcinoma in situ (DCIS).